Gaudillat. Lea L; Patay. Lea L; Sawka. Caroline C; Baurand. Amandine A; Nambot. Sophie S; Level. Cam...
Scientific advances in genomics are transforming healthcare and prevention. However, they also increase situations of uncertainty, which in turn increase vulnerability not only for patients and their families but also for professionals. Cardiogenetics plays a crucial role in preventing sudden death in young individuals, but it can pose complex challenges for healthcare teams. To study professionals' perspectives and experiences regarding cardiogenetics-related vulnerability, a national online survey was conducted in France to gather insight from professionals involved in the care pathway of individuals with cardiogenetic conditions. The survey targeted clinical geneticists, genetic counselors, cardiologists, nurses, and psychologists, in collaboration with the CARDIOGEN network. Out of 86 respondents, the majority (64%) reported experiencing vulnerability, which was not correlated with their profession, experience, or the organization of their clinics. Acknowledged vulnerabilities were mainly related to uncertainties regarding incomplete penetrance, variable expression, and genotype-phenotype disparities in cardiogenetics, exacerbated by the evolving interpretation of genetic data, due to the increased access to genomics. Additionally, the implications of these issues, particularly in cases of unexplained sudden deaths that necessitated genetic investigations and family follow up recommendations, raised further concerns. The reported vulnerabilities encompassed both the need for specialized knowledge and the structural complexities of teams combining skills in genetics and cardiology. In addition, the professionals' capacity to empathize can add a degree of vulnerability. Finally, it seems important to focus on how cardiogenetics teams are organized, particularly through close collaboration among genetics and cardiology units, which could help reduce this feeling of vulnerability.
Mesterházi. András A; Barta. Miklós M; Zubek. László L
Rapid differential diagnosis of circulatory failure (shock) with unknown etiology is a daily challenge in the field of emergency medicine. The Rapid Ultrasound in Shock (RUSH) protocol is well known since 2010. With the use of targeted steps, the 4 forms of shock (cardiogen, distributive, obstructive, hypovolemic) can be separated in a few minutes.
The aim of the authors was to evaluate the usefulness of the Rapid Ultrasound in Shock protocol for the diagnosis of different forms of shock.
The retrospective study included 123 critically ill patients admitted to the Emergency Department of Markusovszky Hospital, Szombathely, Hungary. Detailed records were obtained from all patients.
From the 123 crirically ill patients, 64 patients suffered from circulatory failure, while the remaining patients had acute severe chest or abdominal pain, or respiratory failure.
Based on the results of the first evaluation of the Rapid Ultrasound in Shock protocol in Hungarian patients, the authors conclude that, the bedside ultrasonography has a great value in emergency medicine, and this the protocol is suitable for its integration into patient care and education of emergency medicine.
Zöllei. Éva É; Bari. Gábor G; Blaskovics. Ivett I; Bodó. Kinga K; Csorba. Z...
This study describes how a Hungarian hospital used extracorporeal membrane oxygenation (ECMO) on 14 very sick patients with severe lung or heart failure. Nine patients survived and were discharged, while five died in the ICU and three more later in the hospital. The outcomes were similar to what larger studies have reported, showing that the program is feasible in that setting.
Ahmadi. Ali A; Klein. Ran R; Lewin. Howard C HC; Beanlands. Rob S B RSB; deKemp. Robert A RA
This study compares two commercial Rubidium‑82 generators used for heart PET scans, showing that one system (RUBY‑FILL) consistently produces more usable radioactivity than the other (CardioGen‑82) because of differences in how the activity is measured and delivered.
Moody. Jonathan B JB; Hiller. Kerri M KM; Lee. Benjamin C BC; Corbett. James R JR; Ficaro. Edward P...
The study looked at how accurately a medical imaging device (CardioGen‑82) delivers tiny amounts of a radioactive tracer (Rb‑82) without recalibrating each time. It found that at low doses the device under‑delivers, sometimes by more than 10%, and that leftover tracer in the system causes the mismatch. This information is mainly useful for hospital PET labs, not for DIY health experiments.
Pillai. Satish K SK; Chang. Arthur A; Murphy. Matthew W MW; Buzzell. Jennifer J; Ansari. Armin A; Wh...
Error: Malformed JSON response.
Ferrari. Julia J; Flamm-Horak. Agathe A; Lischka-Lindner. Agnes A; Knoflach. Michael M; Schnabl. Ste...
This study looked at over 11,000 stroke patients and found that a small percentage got worse after being admitted. It identified diabetes, high blood pressure, heart‑related emboli, and large‑vessel disease as risk factors for mild worsening, and older age, higher initial stroke severity, plus the same vascular risk factors for major worsening. The findings are about clinical stroke care, not about the peptide cardiogen or any self‑directed health‑optimization protocol.
Crotti. Lia L; Spazzolini. Carla C; Nyegaard. Mette M; Overgaard. Michael T MT; Kotta. Maria-Christi...
This study looks at people with rare genetic mutations in calmodulin (CALM genes) that cause dangerous heart rhythm problems, especially in kids. It describes how often these patients have heart events, some also have brain issues or heart structural defects, and notes that doctors still don’t have clear treatment guidelines.
Brito. Dulce D; Albrecht. Fabiano Castro FC; de Arenaza. Diego Perez DP; Bart. Nicole N; Better. Nat...
This paper reviews transthyretin amyloid cardiomyopathy (ATTR-CM), a serious heart disease, and discusses how to diagnose and treat it early, especially at specialized centers. It does not mention the peptide cardiogen or give any guidance on using peptides for health optimization.
Zhan. Zhong-Qun ZQ; Wang. Chong-Quan CQ; Wang. Zhi-Xiao ZX; Nikus. Kjell C KC; Baranchuk. Adrian A;...
In patients with acute pulmonary embolism who also have negative T‑waves on their ECG, the presence of ST‑segment deviation (a shift in the ECG line) signals a higher risk of serious problems like low blood pressure, shock, and death within 30 days. When the ECG looks relatively normal, the outlook is much better.
Fauvel. Charles C; Damy. Thibaud T; Berthelot. Emmanuelle E; Bauer. Fabrice F; Eicher. Jean-Christop...
The 2022 European guidelines lowered the cut‑offs for diagnosing post‑capillary pulmonary hypertension (pcPH) in heart‑failure patients. Using the new limits (mean pulmonary artery pressure > 20 mmHg and pulmonary vascular resistance > 2 WU) catches more people with the condition, and both numbers still predict a higher chance of death or hospitalisation.
Albenque. Grégoire G; Bézard. Mélanie M; Kharoubi. Mounira M; Odouard. Shirley S; Lun...
This study looked at people with a rare genetic form of heart‑related amyloidosis. It found that those who have two copies of the V122I mutation (homozygous) develop symptoms and serious heart problems about 8‑10 years earlier than those with just one copy (heterozygous). The research mainly describes disease timing and severity, not any new treatment or lifestyle tip.
Kharoubi. Mounira M; Bézard. Mélanie M; Broussier. Amaury A; Galat. Arnault A; Gounot. Rom...
Error: Malformed JSON response.
Deux. Jean-François JF; Brugières. Pierre P; Kharoubi. Mounira M; Zaroui. Amira A; Oghina....
A study found that people with a heart disease called transthyretin cardiac amyloidosis have lower MRI T1 values in wrist tissues compared to healthy folks. This could hint that wrist MRI might help spot early amyloid buildup, but the finding is still early and needs more research.
Volpentesta. Eugenia E; Kharoubi. Mounira M; Donadio. Cristiano C; Rebiai. Kahina K; Fanen. Pascale...
Error: Malformed JSON response.
Réant. Patricia P; Kharoubi. Mounira M; Donal. Erwan E; Bauer. Fabrice F; Bézard. Mél...
This paper describes a new European registry that will collect detailed information on people with cardiac amyloidosis, a rare heart disease. It’s a big data‑gathering project, not a study of a drug or a peptide, and it doesn’t give any direct advice or protocols you can use right now.
Verdonschot. Job A J JAJ; Kaski. Juan Pablo JP; Asselbergs. Folkert W FW; Behr. Elijah R ER; Charron...
Genetic family screening following the detection of a pathogenic or likely pathogenic variant in a proband with dilated cardiomyopathy (DCM) remains one of the main applications of genetic testing. While cardiac screening is recommended for all first-degree relatives, the a priori risk among family members varies. Consequently, screening regimens should be tailored according to both genetic and clinical information at the individual and familial level. This clinical consensus statement provides tools to help with the risk assessment and follow-up of screening for family members and discusses the utility for integration of genotype-specific information, cardiac imaging, and electrocardiogram findings to personalize cardiac screening regimens, which in conjunction will likely improve individualized risk prediction. Early phenotypic detection of DCM in family members remains an active area of research and innovation. In addition, data are starting to accrue on the utility of early therapeutic intervention in family members with very mild phenotypes that may inform future management in addition to screening. A systematic strategy is proposed to determine the a priori risk of developing DCM for a family member, and the potential of integrating genotype-phenotype knowledge towards family management. Lastly, there is a focus on the current knowledge gaps and ongoing and future opportunities to improve risk prediction, early disease detection, and treatment of family members of patients with DCM.
Padovani. Paul P; Hauet. Quentin Q; Lefort. Bruno B; Chauviré-Drouard. Anne A; Letellier. Marin...
This paper describes a planned study that will test whether using simulated patient encounters can improve how pediatric heart doctors talk to families about serious heart conditions. It’s a training program for doctors, not a drug or supplement, and it doesn’t provide any health‑optimizing tips for everyday people.
Garcia-Pavia. Pablo P; Gonzalez-Lopez. Esther E; Anderson. Lisa J LJ; Cappelli. Francesco F; Damy. T...
This clinical consensus statement, developed by the Heart Failure Association of the European Society of Cardiology, offers a detailed review of the non-specific management of transthyretin amyloid cardiomyopathy (ATTR-CM). This progressive and often fatal condition is increasingly recognized as a major contributor to heart failure. This document provides advice on symptom management and enhancing quality of life, with a focus on volume management, neurohormonal modulation, and tailored use of diuretics and other supportive therapies that address the distinct pathophysiology of ATTR-CM. It also explores advanced treatment modalities such as heart transplantation and mechanical circulatory support, which play crucial roles in managing advanced stages of the disease. Furthermore, it addresses the management of aortic stenosis in the context of ATTR-CM, advising transcatheter aortic valve replacement as the preferred treatment for these patients. The advice provided in this document relies primarily on expert opinion and retrospective studies due to a notable lack of randomized clinical trials, which underscores a critical research gap and the pressing need for evidence-based treatment protocols.
Pompougnac. Julie J
The study looks at how caregivers cope with patient death by creating group spaces to share and make sense of the loss. It focuses on psychological processes, not on any peptide or health‑optimizing intervention.